11 min
MariMed | Jon Levine MJBulls: Cannabis investing and cannabis fundraising
-
- Investing
"MRMD: The Undervalued Cannabis Stock with 14 Consecutive Growth Quarters"
Jon Levine, CEO of MariMed joins Dan Humiston to discusses the evolution of MariMed from a cannabis advising company into one of the industry's leading multi-state operators. The company's strategic plan involves rolling up partners, expanding organically in current states, and exploring opportunities in new markets. They also touch upon the potential impacts of cannabis rescheduling from Schedule 1 to Schedule 3, and how MariMed's conservative financial approach has led to 14 consecutive quarters of growth. John provides insights into their growth strategies and their stock symbol, MRMD. He emphasizes the importance of responsible growth in the cannabis industry.
Produced by PodConx
"MRMD: The Undervalued Cannabis Stock with 14 Consecutive Growth Quarters"
Jon Levine, CEO of MariMed joins Dan Humiston to discusses the evolution of MariMed from a cannabis advising company into one of the industry's leading multi-state operators. The company's strategic plan involves rolling up partners, expanding organically in current states, and exploring opportunities in new markets. They also touch upon the potential impacts of cannabis rescheduling from Schedule 1 to Schedule 3, and how MariMed's conservative financial approach has led to 14 consecutive quarters of growth. John provides insights into their growth strategies and their stock symbol, MRMD. He emphasizes the importance of responsible growth in the cannabis industry.
Produced by PodConx
11 min